Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study

Importance: The use of anticoagulant therapy with heparins decreased mortality in hospitalized patients with severe coronavirus disease 2019 (COVID-19). Even if enoxaparin and fondaparinux have the same clinical indication for venous thromboembolism (VTE) prevention; to date, there are no data about...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Vincenzo, Cardillo, Giuseppe, Viggiano, Giuseppe Vito, Mangiacapra, Sara, Cavalli, Antonella, Fontanella, Andrea, Agrusta, Federica, Bellizzi, Annamaria, Amitrano, Maria, Iannuzzo, Mariateresa, Sacco, Clara, Lodigiani, Corrado, Castaldo, Giampiero, Di Micco, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729125/
https://www.ncbi.nlm.nih.gov/pubmed/33330530
http://dx.doi.org/10.3389/fmed.2020.569567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729125/
https://www.ncbi.nlm.nih.gov/pubmed/33330530
http://dx.doi.org/10.3389/fmed.2020.569567

Ejemplares similares